| 169531 | 169531 | Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido | Completed | No Results Available | Hypoactive Sexual Desire Disorder | Drug: Testosterone Transdermal System|Drug: Placebo patch | https://ClinicalTrials.gov/show/NCT00338312 |
| 169532 | 169532 | Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced Anemia | Completed | No Results Available | Anemia|Chemotherapy | Drug: Epoetin alfa | https://ClinicalTrials.gov/show/NCT00338299 |
| 169533 | 169533 | A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy | Recruiting | No Results Available | Breast Cancer|Neoplasm Metastasis | Other: Standard supportive care (packed RBC transfusion)|Drug: epoetin alfa + packed RBC transfusion | https://ClinicalTrials.gov/show/NCT00338286 |
| 169534 | 169534 | A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode | Withdrawn | No Results Available | Bipolar Disorder | Drug: Aripiprazole|Drug: Placebo | https://ClinicalTrials.gov/show/NCT00338273 |
| 169535 | 169535 | Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133) | Completed | No Results Available | Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart) | Drug: MK0954, /Duration of Treatment : 5 Years|Drug: Comparator : atenolol /Duration of Treatment : 5 Years | https://ClinicalTrials.gov/show/NCT00338260 |
| 169536 | 169536 | EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer | Active, not recruiting | No Results Available | Neoplasms, Breast | Drug: lapatinib + capecitabine | https://ClinicalTrials.gov/show/NCT00338247 |
| 169537 | 169537 | Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative Patients | Completed | No Results Available | Anemia|Intensive Care|Cardiac Surgery | | https://ClinicalTrials.gov/show/NCT00338234 |
| 169538 | 169538 | Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition | Withdrawn | No Results Available | Diarrhea, Malnutrition | Drug: alanyl-glutamine|Drug: glycine | https://ClinicalTrials.gov/show/NCT00338221 |
| 169539 | 169539 | Adult Providing Access to the Visual Environment (PAVE) - Glaucoma Pilot | Completed | No Results Available | Glaucoma | Behavioral: Training in the Use of Low Vision Devices | https://ClinicalTrials.gov/show/NCT00338208 |
| 169540 | 169540 | Assessment and Treatment of Caffeine Dependence | Completed | No Results Available | Self-identified Problematic Caffeine Use|DSM-IV Substance Dependence as Applied to Caffeine | Behavioral: Individualized caffeine cessation instructions | https://ClinicalTrials.gov/show/NCT00338195 |
| 169541 | 169541 | AZD1152 in Patients With Advanced Solid Malignancies | Active, not recruiting | No Results Available | Tumors | Drug: AZD1152 | https://ClinicalTrials.gov/show/NCT00338182 |
| 169542 | 169542 | Observational Study of the Remodelling Process Following Myocardial Infarct | Completed | No Results Available | Heart Failure|Myocardial Infarct | | https://ClinicalTrials.gov/show/NCT00338156 |
| 169543 | 169543 | A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies | Completed | No Results Available | Psoriasis | Drug: efalizumab | https://ClinicalTrials.gov/show/NCT00338143 |
| 169544 | 169544 | Randomised Study to Compare the Efficacy of AZD6244 vs TMZ | Completed | No Results Available | Melanoma | Drug: AZD6244|Drug: Temozolomide | https://ClinicalTrials.gov/show/NCT00338130 |
| 169545 | 169545 | Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease | Completed | No Results Available | Alzheimer's Disease|Dementia | Drug: Galantamine hydrobromide | https://ClinicalTrials.gov/show/NCT00338117 |
| 169546 | 169546 | Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin | Completed | Has Results | Hyperglycemia|Diabetes | Drug: insulin glargine|Drug: insulin glargine|Drug: insulin glargine | https://ClinicalTrials.gov/show/NCT00338104 |
| 169547 | 169547 | Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency | Terminated | No Results Available | Renal Insufficiency,Chronic|Disease Progression|Proteinuria|Dose-Response Relationship,Drug|ACE Inhibitor|Angiotensin II Type 1 Receptor Blockers | Drug: Benazepril|Drug: Losartan | https://ClinicalTrials.gov/show/NCT00338091 |
| 169548 | 169548 | Nocturnal Oxygen Treatment in Heart Failure and Cheyne-Stokes Respiration | Completed | No Results Available | Heart Failure | Device: nocturnal oxygen treatment from oxygen concentrators | https://ClinicalTrials.gov/show/NCT00338078 |
| 169549 | 169549 | External Influences Upon Ocular Homeostasis | Recruiting | No Results Available | Intraocular Pressure | Behavioral: 1. Postural change and 2. Water drinking | https://ClinicalTrials.gov/show/NCT00338065 |
| 169550 | 169550 | Study of Bleeding With Extended Administration of an Oral Contraceptive | Completed | No Results Available | Contraception | Drug: Norethindrone 1 mg / ethinyl estradiol 20 mcg | https://ClinicalTrials.gov/show/NCT00338052 |
| 169551 | 169551 | Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients | Completed | Has Results | Pancreatic Cancer | Drug: Cetuximab|Drug: Gemcitabine|Drug: Oxaliplatin|Drug: Capecitabine|Radiation: Radiotherapy | https://ClinicalTrials.gov/show/NCT00338039 |
| 169552 | 169552 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | Completed | No Results Available | Tumors|Glioma|Colorectal Cancer|Lung Cancer|Breast Cancer|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer | Drug: ECO-4601 | https://ClinicalTrials.gov/show/NCT00338026 |
| 169553 | 169553 | Patient Sleep Position Questionnaire | Completed | No Results Available | Sleep | | https://ClinicalTrials.gov/show/NCT00338013 |
| 169554 | 169554 | EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure | Completed | No Results Available | Chronic Renal Failure | Drug: Epoetin alfa | https://ClinicalTrials.gov/show/NCT00338000 |
| 169555 | 169555 | A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma | Completed | Has Results | Peripheral T-Cell Lymphoma | Drug: Ontak|Drug: CHOP (cyclophosphamide (C), adriamycin (H), vincristine (O), and prednisone (P)) chemotherapy | https://ClinicalTrials.gov/show/NCT00337987 |
| 169556 | 169556 | Computer-Based Training for Cognitive Enhancement | Completed | No Results Available | Cognitive Decline | Procedure: Computer-based training for cognitive enhancement | https://ClinicalTrials.gov/show/NCT00337974 |
| 169557 | 169557 | Optic Nerve Sheath Fenestration | Completed | No Results Available | Optic Nerve Sheath Fenestration | Procedure: Optic Nerve Sheath Fenestration | https://ClinicalTrials.gov/show/NCT00337961 |
| 169558 | 169558 | An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four Weeks | Completed | No Results Available | Chemotherapy|Anemia|Cancer | Drug: Epoetin alfa | https://ClinicalTrials.gov/show/NCT00337948 |
| 169559 | 169559 | A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities. | Completed | Has Results | Renal Failure , Chronic|Anemia | Drug: Epoetin Alfa|Other: Standard of care | https://ClinicalTrials.gov/show/NCT00337935 |
| 169560 | 169560 | Pharmacokinetic Study Of EPZICOM Tablet | Completed | No Results Available | HIV Infection | Drug: Lamivudine / Abacavir Sulfate | https://ClinicalTrials.gov/show/NCT00337922 |